Skip to main content
  • Global
  • MedTech

First Quarter of 2024: Global Medical Device Regulatory Harmonization is the Theme

Global regulatory harmonization for medical devices appears to be the theme to start the year. Read Emergo by UL’s 2024 medical device regulatory insights.

  • Asia Pacific
  • MedTech

Emergo by UL Presents on European Regulation 2023/607 at KIMES 2024

To continue our KIMES 2024 medical device regulation coverage, we discuss our presentation on European Regulation 2023/607.

Emergo by UL Presents on the U.S. FDA eSTAR at Korea’s KIMES 2024

At Korea’s KIMES 2024 we revealed regulatory tips, including an overview of the current U.S. eSTAR template for submitting 510(k)s or De Novo reclassification applications to the U.S. FDA.

  • Asia Pacific
  • MedTech

Australian TGA Updates Recall Reforms Program, Releases Version 2.4 of the URPTG

The Australian Therapeutic Goods Administration (TGA) communicated an update March 26, 2024 on its Recall Reforms Program for medical devices.

  • Global
  • MedTech

New Guidance on Clinical Investigation Plans for Medical Devices

The recitals of the Medical Devices Regulation (MDR) (EU) 2017/745 explain the importance of aligning clinical investigation provisions with ISO 14155.

  • Global
  • MedTech

WHO Announces Submissions Call for WHO Model List of Essential In Vitro Diagnostics

The World Health Organization announced a call for submissions (March 20, 2024) for its fifth Essential Devices List (EDL); an evidence-based health policy document analogous to the WHO Essential Medicines List.

Pathway to MDSAP Whitepaper

Learn more about the steps in the MDSAP transition process.

  • Latin America
  • MedTech

Brazil Medical Device Regulator Delivers on Commitment to Publish Legislative Updates

As Brazil’s ANVISA RDC 848/2024 becomes mandatory in 180 days, medical device and IVD manufacturers must assess the additional compliance requirements and update their Essential Safety and Performance Requirement checklists.

Hospitalar 2024

Schedule a meeting to learn more about how we can support you in getting to market faster.

  • Asia Pacific
  • MedTech

South Korea Regulator Accepts MDSAP Certificates Eliminating On-Site K-GMP Audits

In our third article in a series, we take a look at how manufacturers can submit MDSAP Certificates in Place of on-site K-GMP audits.